MEDIFICE
Timeline
12 events since 2020Board
Filings
Financial
Establishments
2020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 28 days late
2025
Highest result from 2021 to 2025 net €29,898 ▲2,293% The operating result of €61,197 and the net result of €29,898 are both a record.
Appointment: (director)General meeting of 23-07-20252 points ▸
- General meeting, 23-07-2025
- Director appointment,
- The deed holds 1 more point.
Annual accounts 2024 filed PDFmicro format · 14 days before the deadline
2024
Back to profit net €1,249 The net result is €1,249, after 3 loss-making years.
Annual accounts 2023 filed PDFmicro format · 6 days before the deadline
2023
Liquidity more than 10 times current ratio 7.57 The current ratio rises from 0.69 to 7.57.
Annual accounts 2022 filed PDFmicro format · 30 days late
2022
Annual accounts 2021 filed PDFmicro format · 26 days late
2021
Resignation: (director)Transfer of shares from · General meeting of 13-07-20213 points ▸
- General meeting, 13-07-2021
- Director resignation,
- Share transfer,
2020
IncorporationFounders: , and · 120 shares · Appointments: , and · published on 03-11-20208 points ▸
- Founder,
- Founder,
- Founder,
- 120 shares
- Registered office clause, Rue du Dessus 60, 1450 Chastre (Cortil-Noirmont)
- Director appointment,
- Director appointment,
- Director appointment,
- The deed holds 7 more points.
First establishment Rue du Dessus 60, Chastre
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank